NCT00096421
Completed
Phase 3
Tight Glycemic Control in Patients Hospitalized in a Medical-Surgery Intensive Care Unit: A Randomized Study
Hospital Pablo Tobón Uribe1 site in 1 country504 target enrollmentJuly 2003
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Critical Illness
- Sponsor
- Hospital Pablo Tobón Uribe
- Enrollment
- 504
- Locations
- 1
- Primary Endpoint
- Mortality in the next 28 days
- Status
- Completed
- Last Updated
- 19 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the impact of tight control of serum glucose levels with an intensive insulin treatment in patients hospitalized in an intensive care unit with medical and surgical patients.
Detailed Description
Reduction of morbidity-mortality in critical care patients with tight glycemic control had been proven in surgical patients only. Study Hypothesis: In critical care patients, medical or surgical, a glucose serum level between 80 - 110 mg/dL means a lower mortality than patients with glucose levels of more than 110 mg/dL.
Investigators
Eligibility Criteria
Inclusion Criteria
- •15 years of age or older,
- •Probability of staying in critical care for more than 48 hours,
- •Agreement with the informed consent.
Exclusion Criteria
- •Pregnancy,
- •Participating in other trials,
- •Diabetic keto-acidosis or diabetic hyperosmolar state,
- •Do-not-resuscitate orders,
- •Reentry to the critical care unit of the same patient.
Outcomes
Primary Outcomes
Mortality in the next 28 days
Secondary Outcomes
- Days of ventilatory support
- Acute renal failure requiring dialysis or hemofiltration
- Mortality during intensive care
- Mortality overall in-hospital
- Mortality among patients who remained in the intensive care unit for more than five days
- Infections incidence in the critical care unit: nosocomial pneumonia, urinary tract infection and catheter related infection
- Length of stay in the unit
- The median number of red-cell transfusions
- SOFA score
- Critical-illness polyneuropathy
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Phase 3
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)LeukemiaLymphomaNCT00500240M.D. Anderson Cancer Center52
Completed
Phase 1
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.Acute Myocardial InfarctionNCT00209144Emory University58
Active, not recruiting
Phase 3
Tight Versus Liberal Blood Glucose Control in Adult Critically Ill PatientsCritical IllnessHyperglycemiaNCT03665207KU Leuven9,230
Completed
Phase 4
Intraoperative Glucose Control in Liver TransplantLiver TransplantNCT00780026University of Michigan100
Terminated
Phase 4
Tight Intra-Operative Glucose Control During Coronary Artery Bypass SurgeryCoronary Artery BypassNCT00394303Rabin Medical Center1,400